Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.

被引：0
|
作者：
Hurtado, Alicia
Garcia-Donas, Jesus
Garrigos, Laia
Lainez, Nuria
Redondo, Andres
Fernando Cueva, Juan
Santaballa, Ana
Jesus Rubio, Maria
Palaclo, Isabel
Bover, Isabel
Antonio Lopez-Guerrero, Jose
Prieto, Mario
Garcia-Casado, Zaida
Hernando Polo, Susana
Romero, Nuria
Grande, Enrique
机构：
[1] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[2] Ctr Integral Oncol Clara Campal, Madrid, Spain
[3] Hosp del Mar, Barcelona, Spain
[4] Complejo Hosp Navarra, Pamplona, Spain
[5] Hosp Univ La Paz, Madrid, Spain
[6] Complexo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain
[7] Hosp Univ La Fe, Valencia, Spain
[8] Politecn La Fe, Valencia, Spain
[9] Hosp Reina Sofia Cordoba, Cordoba, Spain
[10] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain
[11] GEICO, Mallorca, Spain
[12] Son Llatzer Univ Hosp, Mallorca, Spain
[13] Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain
[14] Ctr Integral Oncol Clara Campal, Madrid, Spain
[15] Fdn Inst Valenciano Oncol, Valencia, Spain
[16] Hosp Univ Ramon Y Cajal, Dept Med Oncol, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps5626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS5626
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma
    Chowdhury, S.
    Feyerabend, S.
    Loriot, Y.
    Necchi, A.
    Gupta, S.
    Josephs, D. H.
    Rodriguez-Vida, A.
    Srinivas, S.
    Zakharia, Y.
    Nepert, D.
    Wride, K.
    Thomas, D.
    Loehr, A.
    Simmons, A. D.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] Randomized, open-label, phase II trial of gemcitabine with or without bavituximab in patients with nonresectable stage IV pancreatic adenocarcinoma.
    Pandya, Shuchi Sumant
    Wong, Lucas
    Bullock, Andrea J.
    Grabelsky, Stephen A.
    Shum, Merrill Kingman
    Shan, Joseph
    Menander, Kerstin B.
    Reid, Tony R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)aEuro
    Grande, E.
    Capdevila, J.
    Castellano, D.
    Teule, A.
    Duran, I.
    Fuster, J.
    Sevilla, I.
    Escudero, P.
    Sastre, J.
    Garcia-Donas, J.
    Casanovas, O.
    Earl, J.
    Ortega, L.
    Apellaniz-Ruiz, M.
    Rodriguez-Antona, C.
    Alonso-Gordoa, T.
    Diez, J. J.
    Carrato, A.
    Garcia-Carbonero, R.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1987 - 1993
  • [44] A Multi-Institutional Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
    Kulke, Matthew H.
    Chan, Jennifer A.
    Ryan, David P.
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    Abrams, Thomas
    Regan, Eileen
    Brady, Rachel
    Weber, Jill
    Campos, Tiffany
    Kvols, Larry K.
    Strosberg, Jonathan R.
    PANCREAS, 2013, 42 (02) : 377 - 377
  • [45] An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.
    Moehler, M. H.
    Hartmann, J. T.
    Lordick, F.
    Al-Batran, S.
    Reimer, P.
    Trarbach, T.
    Ebert, M. P.
    Daum, S.
    Weihrauch, M.
    Galle, P. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study.
    Wang, Feng
    Qi, Yu
    Meng, Xiangrui
    Fan, Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer
    Smith, John W., II
    McIntyre, Kristi J.
    Acevedo, Patrick V.
    Encarnacion, Carlos A.
    Tedesco, Karen L.
    Wang, Yunfei
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) : 361 - 367
  • [48] Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer
    John W. Smith
    Kristi J. McIntyre
    Patrick V. Acevedo
    Carlos A. Encarnacion
    Karen L. Tedesco
    Yunfei Wang
    Lina Asmar
    Joyce A. O’Shaughnessy
    Breast Cancer Research and Treatment, 2009, 118 : 361 - 367
  • [49] A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
    Hickish, Tamas
    Cassidy, Jim
    Propper, David
    Chau, Ian
    Falk, Stephen
    Ford, Hugo
    Iveson, Tim
    Braun, Michael
    Potter, Vanessa
    Macpherson, Iain R.
    Finnigan, Helen
    Lee, Chooi
    Jones, Hilary
    Harrison, Mark
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3136 - 3144
  • [50] Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study
    Qu, Yuan-Yuan
    Zhang, Hai-Liang
    Guo, Hongqian
    Luo, Hong
    Zou, Qing
    Xing, Nianzeng
    Xia, Shujie
    Sun, Zhongquan
    Zhang, Xuepei
    He, Chaohong
    Cai, Jinling
    Zhang, Xiao
    Wang, Quanren
    Ye, Ding-Wei
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5838 - 5846
12345